BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2138448)

  • 1. Elevated levels of soluble CD8 antigen in sera of patients with psoriasis--a possible sign of suppressor/cytotoxic T-cell activation.
    Kapp A
    Arch Dermatol Res; 1990; 282(1):6-7. PubMed ID: 2138448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels.
    Kapp A; Neuner P; Krutmann J; Luger TA; Schöpf E
    Acta Derm Venereol; 1991; 71(5):403-6. PubMed ID: 1684468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasis.
    Kapp A; Piskorski A; Schöpf E
    Br J Dermatol; 1988 Dec; 119(6):707-10. PubMed ID: 3264510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic and suppressor activities in patients with HTLV-I-associated myelopathy.
    Usuku K; Nishizawa M; Osame M; Tabira T
    J Neuroimmunol; 1991 Sep; 33(3):199-205. PubMed ID: 1831463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble E-selectin in sera of patients with atopic dermatitis and psoriasis--correlation with disease activity.
    Czech W; Schöpf E; Kapp A
    Br J Dermatol; 1996 Jan; 134(1):17-21. PubMed ID: 8745880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor versus cytolytic CD8+ T lymphocytes: where are the artefacts?
    Pereira P; Larsson-Sciard EL; Coutinho A; Bandeira A
    Scand J Immunol; 1988 Jun; 27(6):625-8. PubMed ID: 2969138
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of released CD4 and CD8 antigens in the suction-blister fluid and horny-tissue extract in patients with psoriasis.
    Takematsu H; Tagami H
    Br J Dermatol; 1991 Jun; 124(6):550-4. PubMed ID: 1905946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes.
    Baadsgaard O; Fox DA; Cooper KD
    J Immunol; 1988 Mar; 140(6):1738-44. PubMed ID: 2964481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity is increased and telomere length shortened in T cells from blood of patients with atopic dermatitis and psoriasis.
    Wu K; Higashi N; Hansen ER; Lund M; Bang K; Thestrup-Pedersen K
    J Immunol; 2000 Oct; 165(8):4742-7. PubMed ID: 11035119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ; Seyger MM; Van de Kerkhof PC
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD8+ Leu-7+ subset of T cells in Crohn's disease: distinction between cytotoxic and covert suppressor functions.
    Deem RL; Targan SR; Niederlehner A; Shanahan F
    Clin Exp Immunol; 1990 Jun; 80(3):387-94. PubMed ID: 1695560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in CD8+ lymphocytes in atopic dermatitis is associated with a preferential loss of cytotoxic effector cells rather than suppressor inducer cells.
    McCoy JP; Hanley-Yanez K; Tharp MD
    Ann N Y Acad Sci; 1993 Mar; 677():422-4. PubMed ID: 8494231
    [No Abstract]   [Full Text] [Related]  

  • 13. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
    Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
    J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients.
    Pui CH; Ip SH; Dodge RK; Carrabis S; Brown M; Crist WM; Berard CW; Kung P; Dahl GV; Murphy SB
    Blood; 1988 Sep; 72(3):1015-21. PubMed ID: 2970871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of decreased cytotoxic effector CD8+ T lymphocytes in atopic dermatitis by flow cytometry.
    McCoy JP; Hanley-Yanez K; McCaslin D; Tharp MD
    J Allergy Clin Immunol; 1992 Oct; 90(4 Pt 1):688-90. PubMed ID: 1401650
    [No Abstract]   [Full Text] [Related]  

  • 16. Eosinophil cationic protein in sera of patients with atopic dermatitis.
    Kapp A; Czech W; Krutmann J; Schöpf E
    J Am Acad Dermatol; 1991 Apr; 24(4):555-8. PubMed ID: 2033129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals.
    Kägi MK; Wüthrich B; Montano E; Barandun J; Blaser K; Walker C
    Int Arch Allergy Immunol; 1994; 103(4):332-40. PubMed ID: 8130648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships among plasma granzyme B level, pruritus and dermatitis in patients with atopic dermatitis.
    Kamata Y; Kimura U; Matsuda H; Tengara S; Kamo A; Umehara Y; Iizumi K; Kawasaki H; Suga Y; Ogawa H; Tominaga M; Takamori K
    J Dermatol Sci; 2016 Dec; 84(3):266-271. PubMed ID: 27686401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased circulating skin-homing cutaneous lymphocyte-associated antigen (CLA)+ type 2 cytokine-producing cells, and decreased CLA+ type 1 cytokine-producing cells in atopic dermatitis.
    Teraki Y; Hotta T; Shiohara T
    Br J Dermatol; 2000 Aug; 143(2):373-8. PubMed ID: 10951148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
    Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
    J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.